Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
GeneDx Holdings ( (WGS) ) has issued an update.
GeneDx Holdings Corp. announced the appointment of Bryan Dechairo as Chief Operating Officer, a role in which he will oversee key areas including Product & Technology and Operations, as part of the company’s strategy to drive commercial growth and enhance health outcomes through genomic insights. Dr. Dechairo, with over 30 years of experience in diagnostics and pharmaceuticals, is expected to lead operational excellence and accelerate the adoption of genomic insights, positioning GeneDx for growth and scaling its market-leading position in pediatric genetics.
More about GeneDx Holdings
GeneDx is a leader in delivering improved health outcomes through genomic insights with a focus on pediatric genetics. The company offers industry-leading exome and genome tests that translate complex genomic data into clinical answers, personalized health plans, and improved health system efficiencies.
Average Trading Volume: 618,440
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.11B
See more data about WGS stock on TipRanks’ Stock Analysis page.
